Chronic demyelinating polyneuropathy preceding T-cell lymphoma: differentiation between primary neurolymphomatosis and paraneoplastic neuropathy.
Sooyoung KimMyoung-Won LeeSong-Yi ChoiEun Hee SohnPublished in: BMJ case reports (2022)
A 49-year-old man presented with progressive asymmetric weakness and pain. Electrodiagnostic tests and nerve biopsy suggested chronic demyelinating polyneuropathy refractory to immune-modulating therapy. The patient's symptoms were aggravated, and he was finally diagnosed with T-cell lymphoma based on the findings of the second 18 F-2 fluoro-2-deoxy-glucose positron emission tomography/CT performed 16 months after symptom onset. The patient received intravenous chemotherapy, but died 2 months later because of lymphoma progression. A clinical suspicion of neurolymphomatosis and early diagnosis are important for proper management.
Keyphrases
- positron emission tomography
- computed tomography
- case report
- pet ct
- pet imaging
- chronic pain
- multiple sclerosis
- pain management
- diffuse large b cell lymphoma
- image quality
- stem cells
- signaling pathway
- dual energy
- neuropathic pain
- high dose
- squamous cell carcinoma
- magnetic resonance
- blood glucose
- low dose
- sleep quality
- adipose tissue
- bone marrow
- insulin resistance
- mesenchymal stem cells
- cell therapy
- peripheral nerve
- solid state